Several data have showed that EGCG treatment inhibited DNMTs expression and activity, inducing promoter hypomethylation of important tumor suppressor genes, including p16, p21, RARβ, RXRα, MGMT, and MLH1, and inhibiting proliferation and inducing apoptosis of different cancer cell lineages (87–91). The gene discussed is RXRA; the disease is cancer.